Improving Myeloma Outcomes

Ajai Chari, MD

Video Categories: Hematological Malignancies

Dr. Ajai Chari discusses the ultimate goal of improving therapy for myeloma patients. He mentions the COMPASS study, which is working to collect a database of clinical and scientific information on 1000 patients. In the interim, there are some clues, such as an understanding of certain high-molecular-risk patients and some evidence of certain subgroups that have increased response to some new drugs. This allows physicians to be more selective for those who are most likely to benefit from certain therapies.
January 17, 2019

Identifying and Solving Top Challenges to Oncology Biomarker Testing

Drs. David Rimm and Roy Herbst identify the top challenges in the area of biomarker testing as well as solutions to these challenges, including availability of sufficient tissue for a large number of biomarker assays, the time some biomarker tests require for completion, the need for a tight association of [ Read More ]

October 1, 2014

Pharmacy Services Provided to Patients with Polycythemia Vera

Listen as Atheer Kaddis discusses the additional services that pharmacies can prescribe to patients with polycythemia vera and their families.Supported through funding from Incyte